HKB's Mouse Xerophthalmia Models provide pharmaceutical researchers with robust platforms for investigating dry eye disease, one of the most common ocular surface disorders. Our validated rodent models utilize controlled environment exposure, benzalkonium chloride treatment, or scopolamine administration to replicate key features of aqueous-deficient and evaporative dry eye.